Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effects and Safety of GUideline Algorithm Based Intervention on CaRdiovascular and Renal Outcomes in Elderly Diabetic Patients With High Cardiovascular Risk in the Community- A Cluster Randomized Controlled Trial (GUARD-Community Study)

NCT05349955 is registered in ClinicalTrials.gov with Shanghai Zhongshan Hospital as lead sponsor.

NCT NCT05349955
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05349955 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effects and Safety of GUideline Algorithm Based Intervention on CaRdiovascular and Renal Outcomes in Elderly Diabetic Patients With High Cardiovascular Risk in the Community- A Cluster Randomized Controlled Trial (GUARD-Community Study)
Lead sponsor
Shanghai Zhongshan Hospital
Phase
Not applicable
Overall status
Recruiting
Start date
November 21, 2022
Completion date
November 30, 2026
Enrollment
5,600 (estimated)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

cardiovascular complication, diabetic kidney disease, type 2 diabetes